Related Experiment Video
Updated: Jun 15, 2026

11:24
Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains
Published on: March 25, 2015
10.1K
De novo designed peptides for cellular delivery and subcellular localisation
Guto G Rhys1, Jessica A Cross2,3, William M Dawson2
1Department of Biochemistry, University of Bayreuth, Bayreuth, Germany.
Nature Chemical Biology
|July 14, 2022
Summary
Researchers developed a novel synthetic peptide system for targeted delivery of proteins within cells. This system enables de novo polypeptide design for efficient intracellular transport and subcellular localization.
Area of Science:
- Synthetic biology
- Protein engineering
- Cellular delivery systems
Background:
- Designing de novo peptide and protein assemblies from first principles is advancing synthetic polypeptide development.
- Current methods primarily focus on in vitro applications, posing challenges for intracellular delivery.
- Efficiently delivering synthetic polypeptides to specific cellular locations remains a significant hurdle.
Purpose of the Study:
- To design, characterize, and demonstrate the intracellular delivery and subcellular targeting capabilities of a novel de novo synthetic peptide system.
- To create a dual-function peptide for cell penetration and target binding, coupled with a complementary peptide for protein fusion.
- To validate the system's utility in mammalian cells for organelle marking and functional protein complex engagement.
Main Methods:
- De novo computational design of a dual-function basic peptide and a complementary acidic peptide.
- In vitro characterization using biophysical methods and X-ray crystallography.
- Demonstration of intracellular delivery and subcellular localization in mammalian cells.
Main Results:
- Successful design and characterization of a synthetic peptide system with dual functionality (cell penetration and target binding).
- Demonstrated efficient intracellular delivery of the peptide system into mammalian cells.
- Validated subcellular targeting by marking organelles and engaging functional protein complexes.
Conclusions:
- The developed de novo synthetic peptide system offers a promising new strategy for targeted intracellular delivery of proteins.
- This system overcomes previous limitations by enabling efficient delivery and precise subcellular localization of synthetic polypeptides.
- The findings open avenues for advanced applications in cell biology and therapeutic development.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

